---
title: "RBC Capital Keeps Their Hold Rating on Carl Zeiss Meditec (0DHC)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286063564.md"
description: "RBC Capital's Charles Weston has maintained a Hold rating on Carl Zeiss Meditec (0DHC) with a price target of €32.00. Barclays also holds a Hold rating with a price target of €30.00. Weston focuses on the Healthcare sector and has an average return of -6.9% with a 33.20% success rate on his stock recommendations."
datetime: "2026-05-12T08:36:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286063564.md)
  - [en](https://longbridge.com/en/news/286063564.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286063564.md)
---

# RBC Capital Keeps Their Hold Rating on Carl Zeiss Meditec (0DHC)

In a report released today, Charles Weston from RBC Capital maintained a Hold rating on Carl Zeiss Meditec, with a price target of €32.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Weston covers the Healthcare sector, focusing on stocks such as Oxford BioMedica, Oxford Nanopore Technologies PLC, and PolyPeptide Group AG. According to TipRanks, Weston has an average return of \-6.9% and a 33.20% success rate on recommended stocks.

In a report released today, Barclays also maintained a Hold rating on the stock with a €30.00 price target.

### Related Stocks

- [AFX.DE](https://longbridge.com/en/quote/AFX.DE.md)
- [RY.US](https://longbridge.com/en/quote/RY.US.md)
- [OXB.UK](https://longbridge.com/en/quote/OXB.UK.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [Carl Zeiss Meditec (0DHC) Gets a Sell from J.P. Morgan](https://longbridge.com/en/news/286208300.md)
- [ZAWYA: Sidra Medicine advanced Imaging Core recognized as ZEISS labs@location Reference Customer](https://longbridge.com/en/news/286269565.md)
- [A Look At SCHOTT Pharma KGaA (XTRA:1SXP) Valuation After Weaker Profitability In Latest Earnings](https://longbridge.com/en/news/287181929.md)
- [ELFI offers new private student loan alternative for medical and healthcare students facing federal loan changes](https://longbridge.com/en/news/286929682.md)
- [Medicine's Not Going Anywhere: 3 of the Most Resilient Healthcare ETFs](https://longbridge.com/en/news/287197958.md)